Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biocept Inc BIOCQ

Healthcare Biotechnology
Biocept, Inc. is a molecular oncology diagnostics company. The Company focuses on developing and commercializing clinical diagnostic laboratory assays designed to identify rare tumor cells and cell-free tumor deoxyribonucleic acid (DNA) from blood and cerebrospinal fluid (CSF). Its product is branded and trademarked under the name CNSide. CNSide encompasses a suite of cellular and molecular... see more

Recent & Breaking News (GREY:BIOCQ)

20 Stocks Moving In Thursday's Pre-Market Session

Benzinga.com  January 12, 2017

15 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  January 11, 2017

15 Biggest Mid-Day Gainers For Tuesday

Benzinga.com  January 10, 2017

Biocept Secures In-Network Provider Agreement with Blue Cross Blue Shield of Texas

PR Newswire January 10, 2017

Columbia University Medical Center Sponsors Clinical Study Using Biocept's Liquid Biopsy Platform to Evaluate Cerebrospinal Fluid of Breast Cancer Patients for Metastatic Biomarkers

PR Newswire December 27, 2016

Clinical Utility of Biocept's Liquid Biopsy Platform Demonstrated in Study Results Presented at the 2016 San Antonio Breast Cancer Symposium

PR Newswire December 8, 2016

Biocept Presents Robust Analytical Validation Study Results for its PD-L1 Liquid Biopsy Test at the 17th IASLC World Conference on Lung Cancer

PR Newswire December 7, 2016

Biocept to Present at the LD Micro Main Event

PR Newswire November 21, 2016

Biocept Reports 2016 Third Quarter Financial Results

PR Newswire November 9, 2016

Biocept to Release Third Quarter Financial Results and Host Investor Conference Call on November 9, 2016

PR Newswire October 31, 2016

Biocept Appoints David Moskowitz Vice President, Strategy & Corporate Communications

PR Newswire October 27, 2016

Study Results Presented at the 2016 ESMO Annual Congress Demonstrate Leading Clinical Performance with Biocept's ctDNA Liquid Biopsy Platform vs. Tissue Biopsy

PR Newswire October 20, 2016

Biocept Announces Closing of $10 Million Public Offering of Common Stock and Warrants

PR Newswire October 19, 2016

Mid-Day Market Update: Advanced Micro Devices Climbs After Chip Deal With Alibaba; Ocean Power Technologies Shares Slide

Benzinga.com  October 14, 2016

Biocept Announces Pricing of $10 Million Public Offering of Common Stock and Warrants

PR Newswire October 14, 2016

Clinical Results Demonstrating the Performance of Biocept's Target Selector Platform to be Presented at the 2016 European Society of Medical Oncology Annual Congress

PR Newswire September 29, 2016

Biocept's Proprietary Liquid Biopsy Platform to be Featured at Two Upcoming Molecular Diagnostics Conferences

PR Newswire September 23, 2016

Biocept Announces Agreement with Teneovita Medical to Market and Distribute its Liquid Biopsy Testing Platform in Canada

PR Newswire August 30, 2016

Biocept to Present at Next Generation Dx Summit

PR Newswire August 18, 2016

Biocept Comments on Reimbursement Provisions in CMS' Final PAMA Rule

PR Newswire June 29, 2016